Russian Pharmaceutical Industry Leader

Products

Atorvastatin Pharmasyntez
Pharmacotherapeutic group
hypolipidemic agent - HMG-CoA reductase inhibitor
International name
Atorvastatin
Dosage form
tablets
Description Manufacturer Pharmacies Leave a feedback
Atorvastatin is a selective competitive inhibitor of HMG-CoA reductase, a key enzyme that converts Z-hydroxy-Z-methylglutaryl-CoA into mevalonate, a precursor of steroids, including cholesterol. Synthetic hypolipidemic agent.
Send
NAME AND SURNAME*
E-mail
Subject*
Message*
Captcha*
* — Required field